EU MDR Transition

MDR Transition

The European Union (EU) Medical Devices Regulation (MDR) is a comprehensive regulatory framework that governs the safety, effectiveness, and quality of medical devices within the EU. It replaces the previous Medical Devices Directive (MDD) and aims to address the evolving challenges and advancements in the medical device industry.

Scope and Classification

The MDR expands the scope of medical devices to include certain products that were previously unregulated, such as certain aesthetic devices and devices for cleaning, disinfection, and sterilization. It also introduces more specific criteria for device classification, placing a greater emphasis on risk-based classification. This approach ensures that devices with higher risks undergo more stringent regulatory requirements.

Increased Requirements for Clinical Evidence

One of the significant changes introduced by the MDR is the increased emphasis on clinical evidence. Manufacturers are now required to provide comprehensive clinical data to demonstrate the safety and performance of their devices. This includes conducting clinical investigations for certain high-risk devices. The MDR also establishes stricter requirements for clinical evaluation and post-market clinical follow-up to ensure the continuous monitoring of device performance.

Strengthened Post-Market Surveillance

The MDR enhances post-market surveillance (PMS) activities to ensure the ongoing safety and performance of medical devices. Manufacturers must establish robust systems for collecting and analyzing real-world data on device performance and adverse events. Notified Bodies and competent authorities play a more active role in overseeing PMS, including conducting audits and inspections. This proactive approach enables early detection of potential safety issues and facilitates appropriate corrective actions.

Unique Device Identification (UDI) System

To enhance traceability and improve post-market surveillance, the MDR introduces a Unique Device Identification (UDI) system. Each medical device will be assigned a unique identifier, allowing for accurate tracking and retrieval of device-specific information. The UDI system enhances transparency, facilitates recall management, and enables healthcare professionals to access up-to-date information about the devices they use.

Strengthened Role of Notified Bodies

Notified Bodies play a crucial role in the MDR by assessing the conformity of medical devices. The MDR introduces stricter requirements for Notified Bodies, including enhanced competence assessment and increased scrutiny of their operations. The regulation also emphasizes the need for greater coordination and collaboration among notified bodies to ensure consistency in the assessment process. These changes aim to strengthen the reliability and accountability of notified bodies in the conformity assessment process.

Implications for Stakeholders

The MDR has significant implications for various stakeholders in the medical device industry. Manufacturers must invest additional resources and expertise to meet the increased regulatory requirements, including conducting more extensive clinical evaluations and generating robust clinical evidence. Notified Bodies face a greater workload due to the increased scrutiny and requirements for conformity assessments. Healthcare professionals will benefit from improved device safety and performance, as the MDR ensures that only high-quality and clinically validated devices are available on the market.

The EU Medical Devices Regulation (MDR) represents a significant step forward in enhancing the safety, effectiveness, and accountability of medical devices within the European Union. Through its comprehensive provisions, including expanded scope, increased requirements for clinical evidence, strengthened post-market surveillance, and the implementation of the UDI system, the MDR aims to provide patients and healthcare professionals with access to safe and reliable medical devices. While the MDR presents challenges for manufacturers and Notified Bodies, it ultimately serves the greater goal of protecting patients and improving the overall quality of healthcare.

We will help you ensure your medical devices remain compliant and able to be sold within the EU.

Please contact us today to discuss your requirements.

Call us to ensure your medical devices remain compliant

CE Marking

CE Marking

Quality Management System (QMS), Technical File and Risk Management Documentation for the CE Mark.

Read more
MDR Transistion

MDR Transition

We will help you ensure your medical devices remain compliant and able to be sold in the EU.

Read more
IVDR Transistion

IVDR Transition

We will help you ensure your IVDs remain compliant and able to be sold within the EU.

Read more
ISO 27001:2022

ISO 27001:2022

SGB Consulting help you through the audit process to gain ISO 27001:2022 certification.

Read more
ISO 13485:2016

ISO 13485:2016

Allow us to professionally lead you through the audit process to a successful ISO 13485:2016 certification.

Read more
CE Marking

Software QA

We supply Software Quality Assurance and Regulatory Advice to ensure CE Mark or FDA approval.

Read more
CE Marking

Market Access

Helping your company gain access and compliance in all the main markets for medical devices globally.

Read more
Post Brexit Solutions

Post Brexit Solutions

We support foreign device manufacturers to fully comply with the post-Brexit requirements.

Read more
EUDAMED Services

EUDAMED

informed about the latest updates and requirements regarding EUDAMED to ensure compliance.

Read more
Other Medical Device Services

Other Services

As a one-stop-shop for our customers, our services cover everything required for continued compliance.

Read more

Global Market Access & Compliance

We can help you gain access to a wide range of global medical device markets including, but not limited to the following:

uk medical device market access
europe medical device market access
us medical device market access
canada medical device market access
asia medical device market access
australia medical device market access
middle east medical device market access

SGB QA/RA Consulting Ltd.
 

Phone: +44 (0)7933 545591

Address: Future Space
Filton Road
Bristol
England
BS34 8RB

European Healthcare & Device Solutions (Ireland) Ltd.

Phone: +353 (86) 228 0846

Address: Stratton House
Bishopstown Road
Cork
Ireland
T12 Y9TC

Contact Form

Please enter your name.

Please enter your subject.

Please enter your message.

Your message has been sent successfully.

Sorry, error occured this time sending your message.


Copyright 2025 - SGB QA/RA Consulting Ltd